AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22619886
Drug: Oral calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcitriol 0.5 mcg twice weekly
Trial: 22619886
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no oral calcitriol)
Trial: 12175402
Drug: 11 mL
RxNorm normalized name: camphor 0.11 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11 mL of 2% lignocaine gel rectally
Trial: 31356704
Drug: Cognitive Processing
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Processing Therapy for PTSD
Trial: 17576867
Drug: Rivaroxaban 20
RxNorm normalized name: rivaroxaban 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 20 mg BID
Trial: 1945511
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy for 24 hours postoperatively
Trial: 26603251
Drug: Needling treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needling treatment
Trial: 19967342
Drug: Efavirenz (EFV)
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz (EFV) + 2 nucleoside reverse transcriptase inhibitors (2NRTI) once daily
Trial: 12871555
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C treatment (1 g day‐1 for 5 days)
Trial: 6371627
Drug: melphalan and
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: melphalan and 5‐fluorouracil daily for four days, repeated every four weeks with megace daily for eight weeks
Trial: 27329612
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of fructose beverage
Trial: 8546555
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine alone
Trial: 7594124
Drug: High-Ca group
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Ca group (1,400 mg Ca per day)
Trial: 11745911
Drug: Linezolid tablets
RxNorm normalized name: Linezolid Tablets
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid tablets administered while fasting
Trial: 11745911
Drug: Linezolid tablets
RxNorm normalized name: Linezolid Tablets
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid tablets administered after a high-fat meal
Trial: 9417761
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of triamcinolonhexacetonid alone (group 2)
Trial: 31122843
Drug: Ultrasound-guided erector
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided erector spinae plane block (ESPB) administered preoperatively
Trial: 14872476
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg etanercept once weekly
Trial: 14872476
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg etanercept twice weekly
Trial: 6375874
Drug: Domperidone 30
RxNorm normalized name: domperidone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 30 mg
Trial: 22925113
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab injection (2 mg/0.08 mL)
Trial: 7802179
Drug: 25 G
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 G Whitacre needle
Trial: 8590781
Drug: Conventional diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional diabetes treatment (control group)
Trial: 10753434
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injection (0.2 ml of a 4-mg/ml dexamethasone solution, 0.8 mg per injection)
Trial: 20171409
Drug: Active patch
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active patch
Trial: 23192219
Drug: Mandated to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandated to community-based outpatient treatment
Trial: 17157120
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro 50/50
Trial: 15329377
Drug: Implant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant treatment (all attachments)
Trial: 24456363
Drug: Korean red
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean red ginseng (5 g/day)
Trial: 24141646
Drug: Parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib 40 mg
Trial: 7912819
Drug: Fluphenazine (FLU)
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine (FLU) 2 mg for 2 weeks, then 4 mg for 4 weeks
Trial: 30805623
Drug: Wheat DDGS
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat DDGS diet (300 g/kg)
Trial: 8606262
Drug: Tirofiban (MK-383)
DrugBank: Tirofiban (DB00775)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tirofiban (MK-383) administered in three sequential dose panels: bolus doses of 5, 10, and 10 microg/kg and continuous infusion doses of 0.05, 0.10, and 0.15 microg/kg per min for 16 to 24 hours
Trial: 29766413
Drug: Plaque disclosure
RxNorm normalized name: Plaquenil
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Plaque disclosure with subsequent oral hygiene (tooth brushing with prior plaque disclosure)
Trial: 28092416
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (360 ELISA units/dose) administered in three different schedules: (i) 0,1,2 months; (ii) 0,1,6 months; (iii) 0,1,12 months
Trial: 25483291
Drug: Metformin 1000mg
RxNorm normalized name: METFORMIN 1000MG/SITAGLIPTIN 50MG TAB
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin 1000mg twice daily
Trial: 19208305
Drug: Active depressor
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active depressor treatment with lisinopril or labetalol
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with stereotactic radiation therapy
Trial: 22150036
Drug: Norovirus VLP
RxNorm normalized name: chikungunya virus antigen, recombinant Senegal strain 37997
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norovirus VLP vaccine
Trial: 21335930
Drug: Physiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy treatment for hip OA
Trial: 11721319
Drug: Atenolol 50-100
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50-100 mg daily (n = 17)
Trial: 20629472
Drug: Besifloxacin ophthalmic
RxNorm normalized name: besifloxacin ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Besifloxacin ophthalmic suspension 0.6%
Trial: 22679720
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment group (CMM or acupuncture combined during rehabilitation)
Trial: 26275583
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (40 IU)
Trial: 11805451
Drug: Topical heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical heat application in subjects with myofascial pain
Trial: 20037560
Drug: Amoxilav and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxilav and xylometazole at the same doses (control group)
Trial: 25524791
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of stimulants and behavioral treatment
Trial: 19606406
Drug: Olanzapine treatment
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine treatment
Trial: 10846380
Drug: Atropine lollipop
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine lollipop (0.25 mg)
Trial: 10930199
Drug: Hydroxyethylstarch (HES)
RxNorm normalized name: hydroxyethylstarch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethylstarch (HES) 10% 500 ml
Trial: 2245382
Drug: Preoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiation therapy (3150 cGy in 18 fractions, 2 to 3 weeks before surgery)
Trial: 8353101
Drug: Preoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiation therapy
Trial: 2723128
Drug: Amitriptyline 150
RxNorm normalized name: amitriptyline 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 150 mg/day for 4 weeks
Trial: 28609128
Drug: Dydrogesterone (duphaston®)
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dydrogesterone (duphaston®) at 10 mg
Trial: 8690806
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of bovine myelin
Trial: 27555187
Drug: Ultrasonography-guided transversus
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonography-guided transversus abdominis plane (TAP) block (0.5 mL/kg of 0.25% bupivacaine)
Trial: 17440005
Drug: Activation of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activation of ICD therapies for atrial tachyarrhythmia (AT)/atrial fibrillation (AF)
Trial: 8598422
Drug: Beta-carotene supplementation
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene supplementation (90 mg/day for 3 weeks)
Trial: 11484954
Drug: Docetaxel +
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel + Mitoxantrone + G-CSF
Trial: 9112326
Drug: Chymopapain injection
RxNorm normalized name: Chymopapain
DrugBank: Chymopapain (DB06752)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chymopapain injection
Trial: 21518677
Drug: Sirolimus drug-eluting
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus drug-eluting stents (SES)
Trial: 22512878
Drug: Intravenous glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous glutamine
Trial: 19100416
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg twice per day for 12 months
Trial: 10731503
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and folic acid supplements without zinc
Trial: 7829693
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium (25 mmol)
Trial: 3050188
Drug: Ceftizoxime (CZX)
DrugBank: Ceftizoxime (DB01332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftizoxime (CZX) 20 mg/kg intravenous dose
Trial: 19099634
Drug: Thalidomide +
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide + MP chemotherapy (T-MP)
Trial: 27233921
Drug: Calanus oil
RxNorm normalized name: CALANUS OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calanus oil (2 g daily for one year)
Trial: 22510791
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (1400 IU weekly from birth to 6 months)
Trial: 19101220
Drug: Low-dose caldaret
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose caldaret
Trial: 2156887
Drug: Finasteride 50
RxNorm normalized name: Finasteride
DrugBank: Finasteride (DB01216)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Finasteride 50 mg
Trial: 21218388
Drug: Oral antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antioxidant supplementation at nutritional doses
Trial: 29325236
Drug: relamorelin 100
RxNorm normalized name: Relamorelin
DrugBank: Relamorelin (DB12678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: relamorelin 100 μg subcutaneously daily
Trial: 15226212
Drug: Postmenopausal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmenopausal hormone therapy (PHT)
Trial: 10669272
Drug: Ropivacaine 0.75%
RxNorm normalized name: ROPivacaine 0.75% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.75% plus 0.150 mg clonidine (Group II)
Trial: 12755242
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg prostaglandin E2 vaginal tablets
Trial: 30157896
Drug: 3 monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3 monthly ART supply at facilities
Trial: 20618595
Drug: Walking exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Walking exercise (daily from 18 weeks of gestation to the end of pregnancy)
Trial: 21865944
Drug: Moderate glycemic
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate glycemic control (120‐180 mg/dL)
Trial: 2195425
Drug: Silymarin (Legalon)
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin (Legalon) therapy
Trial: 31050956
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy (Bioptron)
Trial: 26016586
Drug: Verbal oral
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verbal oral health education
Trial: 11152433
Drug: Amoxycillin 1
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 1 g bd
Trial: 7577281
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion of propofol
Trial: 2448428
Drug: Postoperative salvage
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative salvage chemotherapy with BCD and CPDD/ifosfamide (IFO)
Trial: 2448428
Drug: Good responders
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Good responders receiving postoperative chemotherapy in control arm
Trial: 18087084
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g single oral dose azithromycin
Trial: 8087189
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (Ned) 4 mg
Trial: 18313881
Drug: 5-FU-based treatment
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU-based treatment
Trial: 20838060
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg infused over 15 minutes every 3-4 weeks
Trial: 30342638
Drug: Internal medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal medicine clerkships
Trial: 15207890
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once weekly for 4 weeks followed by alendronate 10 mg once daily for 4 weeks
Trial: 23241003
Drug: Sildenafil 25
RxNorm normalized name: sildenafil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 25 mg twice a day for 2 weeks, then 50 mg 3 times a week for 10 weeks
Trial: 24717789
Drug: GSK2190915 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2190915 100 mg
Trial: 10694619
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (1 g in 100 mL of saline solution)
Trial: 26016859
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg magnesium oxide
Trial: 18782316
Drug: Tacrolimus 0.1%
RxNorm normalized name: TACROLIMUS 0.1% OINT,TOP
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.1% ointment (MU)
Trial: 14634544
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol (E(2)) 50 microg
Trial: 21029339
Drug: Angiotensin receptor
RxNorm normalized name: Angiotensin receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor blockers
Trial: 9179457
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (150 mg daily for 30 days)
Trial: 18778916
Drug: Lamotrigine monotherapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine monotherapy
Trial: 27286961
Drug: Hyaluronic acid-carboxymethylcellulose
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid-carboxymethylcellulose treatment (n=30)
Trial: 27707440
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (4,000 IU daily)
Trial: 7918310
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acid ethyl esters (3 g/d) administered to hypertriglyceridemic patients for 24 weeks
Trial: 14519051
Drug: Beta-blockers and
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers and diuretics
Trial: 20087154
Drug: Abacavir (ABC)
DrugBank: Abacavir (DB01048)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abacavir (ABC) + Tenofovir disoproxil fumarate (TDF) dual-therapy
Trial: 12480610
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 microg twice a day
Trial: 16373244
Drug: Red clover
RxNorm normalized name: Red clover
DrugBank: Trifolium pratense pollen (DB15530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red clover isoflavone supplement (80 mg/day)
Trial: 27789350
Drug: DMPA 75
RxNorm normalized name: DMPA
DrugBank: Zytron (DB11768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA 75 mg
Trial: 27789350
Drug: DMPA 150
RxNorm normalized name: DMPA
DrugBank: Zytron (DB11768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA 150 mg
Trial: 19609105
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) at a low dose (3 microg/kg/day)
Trial: 19609105
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) at a conventional dose (6 microg/kg/day)
Trial: 31614532
Drug: Mung bean
RxNorm normalized name: MUNG BEAN
DrugBank: Mung bean (DB10830)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mung bean protein supplementation (18 g/day)